Evaluating Biochemically Recurrent Prostate Cancer: Histologic Validation of 18F-DCFPyL PET/CT with Comparison to Multiparametric MRI.

Liza Lindenberg,Esther Mena,Baris Turkbey,Joanna H. Shih,Sarah E. Reese,Stephanie Harmon,Ilhan Lim,Frank I. Lin,Anita Ton,Yolanda McKinney,Philip Eclarinal,Deborah Citrin,William L. Dahut,Ravi A. Madan,Bradford J. Wood,Venkatesh Krishnasamy,Richard Chang,Elliot Levy,Peter A. Pinto,Janet F. Eary,Peter L. Choyke

Evaluating Biochemically Recurrent Prostate Cancer: Histologic Validation of 18F-DCFPyL PET/CT with Comparison to Multiparametric MRI.

2020

PET/CT with 2-(3-{1-carboxy-5-[(6-[18F]fluoro-pyridine 3-carbonyl)-amino]-pentyl}-ureido)-pentanedioic acid demonstrates high specificity and positive predictive value and adds greater value to pel...

Keywords:

Medicine
Recurrent prostate cancer
Multiparametric MRI
Radiology
PET-CT
predictive value
18F-DCFPyL

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations